Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.

de Masson A, O'Malley JT, Elco CP, Garcia SS, Divito SJ, Lowry EL, Tawa M, Fisher DC, Devlin PM, Teague JE, Leboeuf NR, Kirsch IR, Robins H, Clark RA, Kupper TS.

Sci Transl Med. 2018 May 9;10(440). pii: eaar5894. doi: 10.1126/scitranslmed.aar5894.

PMID:
29743350
2.

Ixazomib-induced cutaneous necrotizing vasculitis.

Alloo A, Khosravi H, Granter SR, Jadeja SM, Richardson PG, Castillo JJ, LeBoeuf NR.

Support Care Cancer. 2018 Feb 1. doi: 10.1007/s00520-018-4052-1. [Epub ahead of print]

PMID:
29392482
3.

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.

Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS; Society for Immunotherapy of Cancer Toxicity Management Working Group.

J Immunother Cancer. 2017 Nov 21;5(1):95. doi: 10.1186/s40425-017-0300-z.

4.

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Cañadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA.

Cancer Discov. 2018 Feb;8(2):196-215. doi: 10.1158/2159-8290.CD-17-0833. Epub 2017 Nov 3.

PMID:
29101162
5.

Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid.

Sowerby L, Dewan AK, Granter S, Gandhi L, LeBoeuf NR.

JAMA Dermatol. 2017 Jun 1;153(6):603-605. doi: 10.1001/jamadermatol.2017.0091. No abstract available.

PMID:
28355425
6.

CD30+ Lymphoproliferative Disorders of the Skin.

Sauder MB, O'Malley JT, LeBoeuf NR.

Hematol Oncol Clin North Am. 2017 Apr;31(2):317-334. doi: 10.1016/j.hoc.2016.11.006. Review.

7.

Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.

Song JS, Tawa M, Chau NG, Kupper TS, LeBoeuf NR.

BMC Cancer. 2017 Mar 16;17(1):200. doi: 10.1186/s12885-017-3194-8.

8.

Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax.

Montero J, Stephansky J, Cai T, Griffin GK, Cabal-Hierro L, Togami K, Hogdal LJ, Galinsky I, Morgan EA, Aster JC, Davids MS, LeBoeuf NR, Stone RM, Konopleva M, Pemmaraju N, Letai A, Lane AA.

Cancer Discov. 2017 Feb;7(2):156-164. doi: 10.1158/2159-8290.CD-16-0999. Epub 2016 Dec 16.

9.

Dermatological adverse events with taxane chemotherapy.

Sibaud V, Lebœuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture ME.

Eur J Dermatol. 2016 Oct 1;26(5):427-443. Review.

10.

Programmed cell death-1 pathway inhibitors in genitourinary malignancies: specific side-effects and their management.

Tripathi A, Kaymakcalan MD, LeBoeuf NR, Harshman LC.

Curr Opin Urol. 2016 Nov;26(6):548-55. doi: 10.1097/MOU.0000000000000332. Review.

PMID:
27517638
11.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekofer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LeBoeuf NR, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A, Bertagnolli MM, Ritz J, Brown M, Long H, Aster JC, Shipp MA, Griffin JD, Weinstock DM.

Cancer Cell. 2016 Jul 11;30(1):183. doi: 10.1016/j.ccell.2016.06.008. Epub 2016 Jul 11. No abstract available.

12.

Successful use of brachytherapy for a severe hidradenitis suppurativa variant.

Paul S, Bach D, LeBoeuf NR, Devlin PM, Lipworth AD.

Dermatol Ther. 2016 Nov;29(6):455-458. doi: 10.1111/dth.12393. Epub 2016 Jul 18.

PMID:
27425163
13.

Ipilimumab for Patients with Relapse after Allogeneic Transplantation.

Davids MS, Kim HT, Bachireddy P, Costello C, Liguori R, Savell A, Lukez AP, Avigan D, Chen YB, McSweeney P, LeBoeuf NR, Rooney MS, Bowden M, Zhou CW, Granter SR, Hornick JL, Rodig SJ, Hirakawa M, Severgnini M, Hodi FS, Wu CJ, Ho VT, Cutler C, Koreth J, Alyea EP, Antin JH, Armand P, Streicher H, Ball ED, Ritz J, Bashey A, Soiffer RJ; Leukemia and Lymphoma Society Blood Cancer Research Partnership.

N Engl J Med. 2016 Jul 14;375(2):143-53. doi: 10.1056/NEJMoa1601202.

14.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekofer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LeBoeuf NR, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A, Bertagnolli MM, Ritz J, Brown M, Long H, Aster JC, Shipp MA, Griffin JD, Weinstock DM.

Cancer Cell. 2016 Apr 11;29(4):574-586. doi: 10.1016/j.ccell.2016.03.008. Erratum in: Cancer Cell. 2016 Jul 11;30(1):183.

15.

Merkel Cell Carcinoma Presenting as Subcutaneous Breast Masses: An Uncommon Presentation of a Rare Neuroendocrine Neoplasm.

Nambudiri VE, Vivero M, Watson AJ, Thakuria M, Ng A, Russell S, Rabinowits G, LeBoeuf NR.

Breast J. 2016 Jan-Feb;22(1):113-5. doi: 10.1111/tbj.12534. Epub 2015 Nov 25. No abstract available.

PMID:
26607182
16.

TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL.

Kirsch IR, Watanabe R, O'Malley JT, Williamson DW, Scott LL, Elco CP, Teague JE, Gehad A, Lowry EL, LeBoeuf NR, Krueger JG, Robins HS, Kupper TS, Clark RA.

Sci Transl Med. 2015 Oct 7;7(308):308ra158. doi: 10.1126/scitranslmed.aaa9122.

17.

Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy.

Goddard AL, Vleugels RA, LeBoeuf NR, O'Farrell DA, Cormack RA, Hansen JL, Kupper TS, Devlin PM.

JAMA Dermatol. 2015 Dec 1;151(12):1354-1357. doi: 10.1001/jamadermatol.2015.3028.

PMID:
26397774
18.

Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicities.

Alloo A, Sheu J, Butrynski JE, DeAngelo DJ, George S, Murphy GF, LeBoeuf NR.

Br J Dermatol. 2015 Aug;173(2):574-7. doi: 10.1111/bjd.13692. Epub 2015 Jul 14. No abstract available.

PMID:
25736577
19.

Case records of the Massachusetts General Hospital. Case 5-2015. A 69-year-old woman with recurrent skin lesions after treatment for lymphoma.

LeBoeuf NR, McDermott S, Harris NL.

N Engl J Med. 2015 Feb 12;372(7):650-9. doi: 10.1056/NEJMcpc1314241. No abstract available.

PMID:
25671258
20.

Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.

Sheu J, Hawryluk EB, Litsas G, Thakuria M, LeBoeuf NR.

Clin Breast Cancer. 2015 Feb;15(1):e77-81. doi: 10.1016/j.clbc.2014.09.003. Epub 2014 Oct 29. No abstract available.

PMID:
25445421
21.

Cutaneous paraneoplastic granulomatous eruptions secondary to metastatic carcinoid tumour.

Cohen JM, Nambudiri VE, Kulke MH, Todd DJ, Murphy GF, LeBoeuf NR.

Br J Dermatol. 2015;172(5):1451-4. doi: 10.1111/bjd.13516. Epub 2015 Mar 27. No abstract available.

PMID:
25388104
22.

Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy.

Lee EQ, Ruland S, LeBoeuf NR, Wen PY, Santagata S.

J Clin Oncol. 2016 Apr 1;34(10):e87-9. doi: 10.1200/JCO.2013.51.1766. Epub 2014 Aug 4. No abstract available.

PMID:
25092772
23.

Update on the biology and clinical management of Merkel cell carcinoma.

Thakuria M, LeBoeuf NR, Rabinowits G.

Am Soc Clin Oncol Educ Book. 2014:e405-10. doi: 10.14694/EdBook_AM.2014.34.e405. Review.

24.

Chlorhexidine gluconate–impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases.

Weitz NA, Lauren CT, Weiser JA, LeBoeuf NR, Grossman ME, Biagas K, Garzon MC, Morel KD.

JAMA Dermatol. 2013 Feb;149(2):195-9.

PMID:
23560299
25.

Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients.

Clark RA, Watanabe R, Teague JE, Schlapbach C, Tawa MC, Adams N, Dorosario AA, Chaney KS, Cutler CS, Leboeuf NR, Carter JB, Fisher DC, Kupper TS.

Sci Transl Med. 2012 Jan 18;4(117):117ra7. doi: 10.1126/scitranslmed.3003008.

26.

Update on the management of high-risk squamous cell carcinoma.

LeBoeuf NR, Schmults CD.

Semin Cutan Med Surg. 2011 Mar;30(1):26-34. doi: 10.1016/j.sder.2011.02.002. Review.

PMID:
21540018
27.

Fatal disseminated Acanthamoeba infection in a liver transplant recipient immunocompromised by combination therapies for graft-versus-host disease.

Young AL, Leboeuf NR, Tsiouris SJ, Husain S, Grossman ME.

Transpl Infect Dis. 2010 Dec;12(6):529-37. doi: 10.1111/j.1399-3062.2010.00535.x.

PMID:
20604904
28.

Linear erosive herpes simplex virus: the 'knife-cut sign' in a patient on high-dose corticosteroids.

LeBoeuf NR, Lieb J, Grossman ME.

Clin Exp Dermatol. 2010 Jul;35(5):557-8. doi: 10.1111/j.1365-2230.2010.03786.x. Epub 2010 Mar 8. No abstract available.

PMID:
20236288
29.

Supplemental Content

Loading ...
Support Center